Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Monogram Technologies Inc. - Common Stock (NQ:MGRM)

2.940 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Monogram Technologies Inc. - Common Stock

< Previous 1 2 Next >
Monogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder Community
Via ACCESS Newswire
Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System
Via ACCESS Newswire
CORRECTION: Monogram Technologies Reports Full Year 2024 Financial Results
Via ACCESS Newswire
Monogram Technologies Reports Full Year 2024 Financial Results
Via ACCESS Newswire
Monogram Technologies to Participate in the 37th Annual ROTH Conference in California March 16-18, 2025
Via ACCESS Newswire
Monogram Technologies Provides Regulatory Update on mBôs TKA System and Clinical Trial Preparation in India
Via ACCESS Newswire
Monogram Technologies Provides 510(k) Submission Update Following Positive Meeting with FDA
Via ACCESSWIRE
Monogram Technologies Reports Third Quarter 2024 Financial Results
Via ACCESSWIRE
Monogram Technologies to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday, March 12, 2025 at 4:30 p.m. Eastern Time
Via ACCESS Newswire
Monogram Technologies Announces Management and Related Parties Complete Open Market Purchases of MGRM Common Stock Totaling $1 Million
Via ACCESSWIRE
Monogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern Time
Via ACCESSWIRE
Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
Via ACCESSWIRE
Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
Via ACCESSWIRE
CORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System
Via ACCESSWIRE
Monogram Technologies Receives FDA Response for mBôs TKA System
Via ACCESSWIRE
Monogram Technologies Reports Second Quarter 2024 Financial Results
Via ACCESSWIRE
Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
Via ACCESSWIRE
Monogram Technologies Announces Preferred Stock Dividends
Via ACCESSWIRE
Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million
Via ACCESSWIRE
Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration
Via ACCESSWIRE
Monogram Technologies Submits 510(k) Application for mBôs TKA System Clearance
Via ACCESSWIRE
Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024
Via ACCESSWIRE
Monogram Orthopaedics Completes Corporate Name Change to Monogram Technologies
Via ACCESSWIRE
Monogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
Via ACCESSWIRE
Monogram Technologies Launches Continuous Offering of 8.00% Convertible Preferred Stock and Warrants
Via ACCESSWIRE
Monogram Orthopaedics Reports First Quarter 2024 Financial Results
Via ACCESSWIRE
Monogram Engages Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S.
Via ACCESSWIRE
Monogram Provides Regulatory Update Following Meeting with FDA
Via ACCESSWIRE
Monogram Accepted to NVIDIA Inception Program
Via ACCESSWIRE
Monogram Orthopaedics to Host Business Update Conference Call on Thursday, March 21st at 5:00 p.m. Eastern Time
Via ACCESSWIRE
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.